|Articles|June 15, 2009
Retina Roundtable Session 1
Advertisement
Subscribe
In this first session, the experts discuss their standard approach when using ranibizumab (Lucentis, Genentech) to treat their patients with age-related macular degeneration.
Participants include:
Return to
Return to
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SparingVision completes PRODYGY trial patient dosing with SPVN06
2
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
3
PRIMA System: A major step in the battle against GA
4
4DMT completes enrollment in 4FRONT-1, phase 3 trial of 4D-150 in AMD
5
























